Pro Share Advisors LLC Kronos Bio, Inc. Transaction History

Pro Share Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$3.12 - $7.52 $40,987 - $98,790	-13,137 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$6.26 - $14.42 $20,545 - $47,326	-3,282 Reduced 19.99%	13,137 $94,000
Q4 2021 Feb 08, 2022	BUY	$11.35 - $21.18 $186,355 - $347,754	16,419 New	16,419 $223,000
Q3 2021 Nov 12, 2021	SELL	$18.17 - $24.7 $182,971 - $248,729	-10,070 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$20.08 - $29.02 $202,205 - $292,231	10,070 New	10,070 $241,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $48.8M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.